© Ann Goodman 2012
Q&A: Following UN Women NYC’s “3 Pillars of Sustainability,” May 8, 2012, Ann talks with Pharmajet’s Heather Potters, Founder and Chair, about the role of business in global health.

1. Ann: PharmaJet is a new medical device company, and your mother developed the technology. What’s the company’s role in furthering sustainable development?
Heather: The company’ mission is to make a positive contribution to reducing the global disease burden through injection delivery of vaccines with its devices, safely and effectively.
2. Ann: How do you do that?
Heather: We’ve developed a simple, innovative needle-free jet injection technology—focused on delivery of vaccines into the body. “Needle-free” is not new, but the way in which PharmaJet has approached it is. A variety of care givers, customers, patients, governments, and NGO’s have used the technology and confirmed it to be very useful and desirable in a variety of healthcare environments, as an alternative to needle-syringe and the resulting disposal, needle-stick, needle re-use and liability issues they face.
3. Ann: Is the traditional vaccination process potentially a global health issue?
Heather: The aim of vaccination is to help the body generate immunity to disease. Continue reading “PharmaJet’s Global Return on Health”